ANTX · Forms 3, 4, 5
Insider trades at AN2 Therapeutics, Inc.
2 insiders sold $318K and 1 insider bought $12K of AN2 Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for AN2 Therapeutics, Inc. (ANTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Gilbert Lynn Marks | Director | Award | 2,283 | Form 4 | |||
| Patricia A. Martin | Director | Award | 389 | Form 4 | |||
| Kabeer Aziz | Director | Award | 2,465 | Form 4 | |||
| Cameron C. Trenor III | Chief Medical Officer | Award | 116,667 | Form 4 | |||
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 523 | $6.02 | $3K | Form 4 | |
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 585 | $6.02 | $4K | Form 4 | |
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 4,725 | $6.02 | $28K | Form 4 | |
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 5,294 | $6.02 | $32K | Form 4 | |
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 2,877 | $6.07 | $17K | Form 4 | |
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 3,223 | $6.07 | $20K | Form 4 | |
| Sarah Joanne Williams | Principal Accounting Officer | Sell | 272 | $5.53 | $2K | Form 4 | |
| Margaret M FitzPatrick | Director | Buy | 2,098 | $5.53 | $12K | Form 4 | |
| Cameron C. Trenor III | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 16,696 | $6.01 | $100K | Form 4 | |
| Robin Shane Readnour | Director | Sell (10b5-1 plan) | 18,706 | $6.01 | $112K | Form 4 | |
| Joseph S Zakrzewski | Director | Gift | 405,880 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.